Randomised, placebo controlled trial of nebulised furosemide for breathlessness in patients with cancer

Thorax
A WilcockA E Tattersfield

Abstract

Breathlessness is a common and difficult symptom to treat in patients with cancer. Case reports suggest that nebulised furosemide can relieve breathlessness in such patients but few data are available. Patients with primary or secondary lung cancer and a Dyspnoea Exertion Scale score of >or=3 were recruited. Following familiarisation, patients received either nebulised furosemide 40 mg or nebulised 0.9% saline under double blind conditions or no treatment, in random order on 3 consecutive days. Patients undertook number reading and arm exercise tests to assess breathlessness and its impact, and were asked to report subjective benefit and any preference between nebulised treatments. 15 patients took part. There were no differences between furosemide, saline and no treatment in the outcomes of the number reading test (eg, mean number read per breath was 6.7, 6.4 and 6.7, respectively) or arm exercise test (eg, mean Borg score at maximum equivalent workload was 2.3, 2.5 and 2.7, respectively). No adverse effects were reported, although there was a small fall in forced expiratory volume in 1 s and forced vital capacity following saline. Six patients considered that their breathlessness improved with nebulised treatment, three prefe...Continue Reading

Citations

Feb 13, 2010·Wiener medizinische Wochenschrift·Steffen T Simon, Claudia Bausewein
Jan 25, 2012·Journal of Palliative Medicine·Arif H KamalAmy P Abernethy
Mar 8, 2011·British Journal of Anaesthesia·T Nishino
Feb 18, 2012·American Journal of Respiratory and Critical Care Medicine·Mark B ParshallUNKNOWN American Thoracic Society Committee on Dyspnea
May 2, 2012·BMC Palliative Care·Phillip J NewtonUNKNOWN Improving Palliative Care through Clinical Trials (ImPaCCT) group
Mar 20, 2014·BMJ Supportive & Palliative Care·Jenifer JebaNikki Pease
May 5, 2010·Current Opinion in Supportive and Palliative Care·Dong Xue, Amy P Abernethy
Apr 2, 2011·Current Opinion in Supportive and Palliative Care·Amy P AbernethyChristopher Cox
May 19, 2010·Expert Review of Respiratory Medicine·Margaret Isaac, J Randall Curtis
Sep 1, 2012·Acta Oncologica·Irit Ben-AharonSalomon M Stemmer
Apr 17, 2012·Heart, Lung & Circulation·Phillip J NewtonPeter Macdonald
Jan 18, 2011·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Shirley ThomasSara Booth
Aug 11, 2015·Current Opinion in Supportive and Palliative Care·Finella CraigMyra Bluebond-Langner
Jun 11, 2014·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Jackelyn Y BoydenJ Cameron Muir
Mar 11, 2017·Expert Review of Respiratory Medicine·Carlo BarbettaMiriam J Johnson
Jan 22, 2010·The Cochrane Database of Systematic Reviews·Asbjørn Hróbjartsson, Peter C Gøtzsche
Jul 25, 2019·Current Opinion in Supportive and Palliative Care·Sara J AbdallahHayley Lewthwaite
Dec 23, 2016·Lung·C R O'DonnellRobert Banzett
Apr 10, 2009·British Journal of Hospital Medicine·S G Oxberry, I Lawrie
Feb 23, 2021·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David HuiMargaret L Campbell
Oct 17, 2017·Respiratory Physiology & Neurobiology·Capucine Morélot-PanziniRobert B Banzett
Apr 23, 2021·Journal of Hospice and Palliative Nursing : JHPN : the Official Journal of the Hospice and Palliative Nurses Association·Margaret L CampbellLynn F Reinke
Sep 14, 2021·The American Journal of Hospice & Palliative Care·Rachel A Zemel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.